Covid-19 protein subunit vaccine – AKS-452
Transportable without cold-chain:
Shelf-stable for over six months at 25° Celsius (77° Fahrenheit)
Maintains potency for one month at 37° Celsius (99° Fahrenheit)
High volume, low cost manufacturing:
Uses established antibody production infrastructure
Single production line can make over one billion doses per year
Does not include mRNA technology, viral vectors, or a weakened SARS-CoV-2 virus
Focused presentation of Receptor Binding Domain (RBD)
Designed to preserve effectiveness against viral variants